Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04856176
Title A Study of Sargramostim Plus Pembrolizumab With or Without Pemetrexed in Patients With Advanced Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Tufts Medical Center

lung non-small cell carcinoma


Carboplatin + Paclitaxel + Pembrolizumab + Sargramostim

Carboplatin + Paclitaxel + Pembrolizumab + Pemetrexed Disodium + Sargramostim

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST